Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001628280-24-006407

Options or other derivatives

  • Director acquired 39,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
JOHNSON DAVID LEE Director 2024-02-20 Grant or award · Option to purchase Common Stock +39,500 39,500 D: show line 1 in the form
Loading xslF345X05/wk-form4_1708639272.xml…